Novo Nordisk picked up European approval for a combination of a long-acting insulin and its own Victoza, pioneering a once-a-day approach to Type 2 diabetes that could bring in blockbuster sales.

…read more

Source: Novo Nordisk wins EU approval for a diabetes combo with billion-dollar potential


0 No comments